Literature DB >> 17901449

Gradations of researchers' obligation to provide ancillary care for HIV/AIDS in developing countries.

Henry S Richardson1.   

Abstract

Three principal factors affect the stringency of medical researchers' obligation to provide antiretroviral treatment to participants in non-HIV/AIDS studies that are conducted in developing countries: (1) the centrality of HIV/AIDS to the study design, (2) the extent of the researcher-participant interaction, and (3) the cost relative to the study budget. I provide a basis for assessing the comparative stringency of the researchers' obligation to provide this type of ancillary care. Practically, given the range of possible responses to study participants' needs, calibrating the researcher's responsibility to provide ancillary care is a useful step in ethical analysis. Theoretically, a gradation of obligation suggests how research ethics committees or institutional review boards can take multiple, potentially conflicting ethical factors into account without undertaking spurious efforts to quantify their importance.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17901449      PMCID: PMC2040358          DOI: 10.2105/AJPH.2006.093658

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  19 in total

1.  Specifying, balancing, and interpreting bioethical principles.

Authors:  H S Richardson
Journal:  J Med Philos       Date:  2000-06

2.  Provision of treatment in HIV-1 vaccine trials in developing countries.

Authors:  Daniel W Fitzgerald; Jean William Pape; Judith N Wasserheit; George W Counts; George W Counts; Lawrence Corey
Journal:  Lancet       Date:  2003-09-20       Impact factor: 79.321

3.  Not if but how? Caring for HIV-1 vaccine trial participants in South Africa.

Authors:  T Tucker; C Slack
Journal:  Lancet       Date:  2003-09-20       Impact factor: 79.321

4.  Ethics guidance for HIV prevention trials.

Authors:  Kathleen M MacQueen; Quarraisha Abdool Karim; Jeremy Sugarman
Journal:  BMJ       Date:  2003-08-09

5.  Medical researchers' ancillary clinical care responsibilities.

Authors:  Leah Belsky; Henry S Richardson
Journal:  BMJ       Date:  2004-06-19

6.  The standard of care debate: can research in developing countries be both ethical and responsive to those countries' health needs?

Authors:  David Wendler; Ezekiel J Emanuel; Reidar K Lie
Journal:  Am J Public Health       Date:  2004-06       Impact factor: 9.308

7.  The ancillary-care responsibilities of medical researchers. An ethical framework for thinking about the clinical care that researchers owe their subjects.

Authors:  Henry S Richardson; Leah Belsky
Journal:  Hastings Cent Rep       Date:  2004 Jan-Feb       Impact factor: 2.683

Review 8.  Reciprocity and post-trial access for participants in antiretroviral therapy trials.

Authors:  Maria Merritt; Christine Grady
Journal:  AIDS       Date:  2006-09-11       Impact factor: 4.177

9.  Effect of nitazoxanide on morbidity and mortality in Zambian children with cryptosporidiosis: a randomised controlled trial.

Authors:  Beatrice Amadi; Mwiya Mwiya; John Musuku; Angela Watuka; Sandie Sianongo; Ayman Ayoub; Paul Kelly
Journal:  Lancet       Date:  2002-11-02       Impact factor: 79.321

10.  The effects of placental malaria on mother-to-child HIV transmission in Rakai, Uganda.

Authors:  Heena Brahmbhatt; Godfrey Kigozi; Fred Wabwire-Mangen; David Serwadda; Nelson Sewankambo; Tom Lutalo; Maria J Wawer; Carlos Abramowsky; David Sullivan; Ronald Gray
Journal:  AIDS       Date:  2003-11-21       Impact factor: 4.177

View more
  18 in total

1.  Incidental findings and ancillary-care obligations.

Authors:  Henry S Richardson
Journal:  J Law Med Ethics       Date:  2008       Impact factor: 1.718

2.  Ancillary care in community-based public health intervention research.

Authors:  Maria W Merritt; Holly A Taylor; Luke C Mullany
Journal:  Am J Public Health       Date:  2009-12-17       Impact factor: 9.308

3.  Compensating clinical trial participants from limited resource settings in internationally sponsored clinical trials: a proposal.

Authors:  Paul Ndebele; Joseph Mfutso-Bengo; Takafira Mduluza
Journal:  Malawi Med J       Date:  2008-06       Impact factor: 0.875

4.  Convergent ethical issues in HIV/AIDS, tuberculosis and malaria vaccine trials in Africa: Report from the WHO/UNAIDS African AIDS Vaccine Programme's Ethics, Law and Human Rights Collaborating Centre consultation, 10-11 February 2009, Durban, South Africa.

Authors:  Nicole Mamotte; Douglas Wassenaar; Jennifer Koen; Zaynab Essack
Journal:  BMC Med Ethics       Date:  2010-03-09       Impact factor: 2.652

5.  Health researchers' ancillary care obligations in low-resource settings: how can we tell what is morally required?

Authors:  Maria W Merritt
Journal:  Kennedy Inst Ethics J       Date:  2011-12

6.  Ancillary care in South African HIV vaccine trials: addressing needs, drafting protocols, and engaging community.

Authors:  Catherine M Slack
Journal:  J Empir Res Hum Res Ethics       Date:  2014-02       Impact factor: 1.742

7.  Ancillary care for public health research in developing countries.

Authors:  Adnan A Hyder; Maria W Merritt
Journal:  JAMA       Date:  2009-07-22       Impact factor: 56.272

8.  It's Time: The Case for PrEP as an Active Comparator in HIV Biomedical Prevention Trials.

Authors:  Bridget Haire
Journal:  J Bioeth Inq       Date:  2014-07-20       Impact factor: 1.352

9.  Excluded, not dismissed: enhancing benefit in clinical research.

Authors:  Maria Nardell; Akansha Chhabra; Lubna Pal
Journal:  Contemp Clin Trials       Date:  2012-09-07       Impact factor: 2.226

10.  Ethical considerations in determining standard of prevention packages for HIV prevention trials: examining PrEP.

Authors:  Bridget Haire; Morenike Oluwatoyin Folayan; Catherine Hankins; Jeremy Sugarman; Sheena McCormack; Gita Ramjee; Mitchell Warren
Journal:  Dev World Bioeth       Date:  2013-05-31       Impact factor: 2.294

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.